You are viewing the site in preview mode

Skip to main content

Table 3 Nasal symptoms and RQLQ scores of AR and NAR patient groups

From: Prevalence of allergic and nonallergic rhinitis in a rural area of northern China based on sensitization to specific aeroallergens

  Clinical ARa Clinical NARb P value
Nasal symptoms, VAS (mean ± SD)
 Itching 4.46 ± 3.50 3.09 ± 2.99 < 0.0001
 Sneezing 1.53 ± 2.66 0.90 ± 0.94 < 0.0001
 Rhinorrhea 4.29 ± 3.41 3.01 ± 2.95 0.004
 Congestion 3.99 ± 3.29 3.42 ± 3.06 0.021
RQLQ (mean ± SD)
 Sleep 4.57 ± 4.61 3.17 ± 3.76 0.019
 Non nasal/eyes 8.8 ± 9.08 6.11 ± 7.29 < 0.0001
 Practical problems 4.92 ± 4.81 3.04 ± 3.77 0.459
 Nasal 6.89 ± 5.94 4.57 ± 4.76 < 0.0001
 Eyes 4.77 ± 5.76 2.91 ± 3.83 0.041
 Emotion 5.38 ± 5.74 3.73 ± 4.79 < 0.0001
  1. VAS, visual analogue scale; RQLQ, the rhinoconjunctivitis quality of life questionnaire
  2. aSelf-reported AR subjects showing positive SPT defined as clinical AR patients, b self-reported AR subjects with negative SPT
Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us